NFKB1 and non-small cell lung carcinoma: GA co-operates with cisplatin to increase the sensitivity of NSCLC cells to cisplatin by inhibiting NF-κB (p65 and p50), MAPK/ERK, MAPK/JNK, and promotes apoptosis in A549 and NCI-H460 cells [23].